Article
Cover
RNJPH Journal Cover Page

RGUHS Nat. J. Pub. Heal. Sci Vol No: 9  Issue No: 3 eISSN: 2584-0460

Article Submission Guidelines

Dear Authors,
We invite you to watch this comprehensive video guide on the process of submitting your article online. This video will provide you with step-by-step instructions to ensure a smooth and successful submission.
Thank you for your attention and cooperation.

Original Article

Sahana Vellal1 , Ramesh Masthi N R2 , Sujay Halkur Shankar3

1: Junior Resident, Department of Obstetrics and Gynecology,

Jagadguru Jayadeva Murugarajendra Medical College, Davangere, India,

2: Professor and Head, Department of Community Medicine, Kempegowda Institute of

Medical Sciences, Bengaluru, India

3: Junior resident, Department of Medicine, All India Institute of Medical Sciences, New Delhi, India

Address for correspondence:

N R Ramesh Masthi

Professor and Head Department of Community Medicine Kempegowda Institute of Medical Sciences, Bengaluru, India. EMail ID: ramesh.masthi@gmail.com

Date of received:15/07/2020                                                                  Date of Acceptance:29/08/2020

Year: 2018, Volume: 3, Issue: 3, Page no. 11-17,
Views: 1064, Downloads: 14
Licensing Information:
CC BY NC 4.0 ICON
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0.
Abstract

Background: Cannabis or Marijuana is a psychoactive drug, one of the commonest recreational drug, and the most common illegal drug across the globe. Chronic effects of this drug are still a fairly research deficit area.

Objective: Of this study is to assess the cognitive effects of chronic cannabis use, using the standardized Montreal Cognitive Assessment Test (MoCA) and contrast the socio-demographic profile between users and non-users.

Materials and Methodology : This was a cross-sectional study conducted in Urban Bengaluru, India between July and September 2016. Males and female students aged between 18 and 25 years were included and grouped into chronic cannabis user, or a Control. The MoCA test was then administered in the subject’s preferred language and assessed based on the defined MoCA administration and grading standards.

Results: A total 62 individuals were recruited. 31 individuals were grouped as cases and a matching 31 individuals were controls. Each group comprised on 29 males and 2 females. There was a significant difference between the total score of the MoCA test in the chronic marijuana user group (Median = 25) when compared to the control group (Median = 28); U = 181, p <0.001. Among the different categories of the MoCA tool, there was a significant difference between the users group and the control group in the categories of Visuo-spatial function, Attention and Language.

Conclusion: Chronic cannabis users were found to have cognitive impairment than those who have never used cannabis.

<p><strong>Background: </strong>Cannabis or Marijuana is a psychoactive drug, one of the commonest recreational drug, and the most common illegal drug across the globe. Chronic effects of this drug are still a fairly research deficit area.</p> <p><strong>Objective: </strong>Of this study is to assess the cognitive effects of chronic cannabis use, using the standardized Montreal Cognitive Assessment Test (MoCA) and contrast the socio-demographic profile between users and non-users.</p> <p><strong>Materials and Methodology :</strong> This was a cross-sectional study conducted in Urban Bengaluru, India between July and September 2016. Males and female students aged between 18 and 25 years were included and grouped into chronic cannabis user, or a Control. The MoCA test was then administered in the subject&rsquo;s preferred language and assessed based on the defined MoCA administration and grading standards.</p> <p><strong> Results: </strong>A total 62 individuals were recruited. 31 individuals were grouped as cases and a matching 31 individuals were controls. Each group comprised on 29 males and 2 females. There was a significant difference between the total score of the MoCA test in the chronic marijuana user group (Median = 25) when compared to the control group (Median = 28); U = 181, p &lt;0.001. Among the different categories of the MoCA tool, there was a significant difference between the users group and the control group in the categories of Visuo-spatial function, Attention and Language.</p> <p><strong>Conclusion: </strong>Chronic cannabis users were found to have cognitive impairment than those who have never used cannabis.</p>
Keywords
marijuana , cognition , memory
Downloads
  • 1
    FullTextPDF
Article

Introduction

Cannabis or Marijuana is a psychoactive drug obtained from various parts of the plant Cannabis sativa. It is one of the commonest recreational drug, and the most common illegal drug across the globe. Known to produce euphoria or a ‘high’ feeling, this drug has become increasingly popular among the youth and even adolescent age groups. The active compound in herbal cannabis, D9- tetrahydrocannabinol, exerts all of its known central effects through the CB1 cannabinoid receptor. CB1 receptors are expressed at particularly high densities in the basal ganglia and cerebellum, so it is not surprising that cannabinoids have complex effects on psychomotor function.1 At doses exceeding the psychotropic threshold, ingestion of cannabis usually causes enhanced well-being and relaxation with an intensification of ordinary sensory experiences. Acute adverse effects caused by overdosing are increased heart rate and changes in blood pressure.2 But chronic effects of this drug is still a fairly research deficit area. Unwillingness of people to openly accept the consumption of an illegal drug is one the main reasons for lack of in-depth studies on this. In a study conducted in Europe, the prevalence of psychiatric disorders in cannabis users, according to DSM-IV criteria in the sample was high. A current mood disorder was present in 48% and an anxiety disorder in 55% of the cannabis users in the last 12 months.3 The World Drug Report 2019 suggests a continued rise in the number of cannabis users worldwide. This rise is also visible in Asian countries although quantification is difficult due to lack of prior survey statistical data. The prevalence of cannabis use in India is estimated to be about 3% of the population aged 18 years and older and at < 1% in adolescents aged between 10 and 17 years. While this number may appear small, the size of the population in the country would put the absolute numbers at about 4 million individuals. The prevalence of cannabis use disorder in those aged between 10 and 75 years stands at 0.7%. The report further describes bhang as the most common form of cannabis consumption, being driven by cultural practices as well.4

India alone carried out 6 per cent of the world’s cannabis herb (“ganja”) seizures in 2016 (nearly 300 tons), and reported seizing even higher quantities in 2017 (353 tons, representing a 20 per cent increase compared with 2016). The figures for 2017 are the highest in India during the period 2013–2018.5 Unlike physical effects of the drug, which can be measured by laboratory tests and simple clinical methods, the effects of the drug on cognition and mental health are rather quite difficult to carry out. Studies in this area, especially in India are very scarce.

The Montreal Cognitive Assessment (MoCA) is a screening tool used in the geriatric population to detect mild cognitive impairment.6 This has found to be more sensitive in this aspect when compared to the more popular Mini-mental state examination (MMSE). We utilized this screening tool for cognitive assessment in cannabis users.7

This study aims to contrast the socio-demographic profile and compare cognitive effects (using the Mica test) between chronic cannabis users and non-users.

Materials and methods

This is a cross-sectional study conducted in Urban Bengaluru, India between July and September 2016. Due to a lack of prior similar studies, we used a sample size of convenience with a snowball sampling technique.

Males and female students aged between 18 and 25 years, from professional colleges of various streams like medicine, engineering, commerce and arts were included in the study. They were grouped as user if they were chronic cannabis users (operational definition is as below) and as a control if they have never consumed cannabis in any form.

Individuals acutely under the influence of the drug during the study, prior diagnosis of a psychiatric or chronic medical illness, prior detection of cognitive impairment, and those unwilling to consent for participation were excluded from the study.

Operational Definition

Chronic cannabis user was defined as an individual who consumed cannabis in any form for three or more days in a week without default for the last six months.

Under the acute influence of cannabis was defined as up to 3 hours following pulmonary assimilation and 12 hours following ingestion.

Socio-demographic data was collected from both cases and controls. The types of marijuana use were categorized as smoking (through a joint or bong), drinking (bhang), and eating (in the form of cake or brownies). Methods used only sparingly (once in a month) were excluded. Time of day was divided into three groups of eight hours each; Morning (from 0600 to 1400), Evening (1400 to 2200), and Night (2200 to 0600). The reasons for use were categorized as peer-pressure, relaxation/ creativity, or stress relief. Multiple options for each of the above variables was acceptable. The MoCA test was then administered in the subject’s preferred language. Instructions on how to complete the assessment was provided by the principal investigator. The assessment was graded based on the defined MoCA administration and grading standards.6

A total score of 26 and above out of 30 is considered normal (no cognitive impairment).The total duration of the exercise was expected to last 10 minutes. The MoCA test has been translated and validated in Kannada and Hindi.8-9

Institutional ethical clearance was obtained (KIMS IEC/UG-32/201)

Confidentiality of the subjects was maintained throughout. The test was performed in private, thus the questions and the subject’s response were heard and noted only by the investigator. The subjects were offered a referral to a health care provider for further management of their drug use.

Statistical Analysis

Data from the study was compiled into Microsoft Excel and statistical analysis was performed on the same platform. The scores for the MoCA test were represented as median and interquartile range. A Mann Whitney U test was use to compare the mean MoCA scores between the controls and cannabis users due to non-normality of data. The confidence interval was set at 95% with an α of 0.05. A two tailed p-value was computed and was considered to be significant < 0.05.

Results

At the end of the study period, a total of n=62 individuals were recruited. 31 individuals were grouped as cases and a matching 31 individuals were controls. Each group comprised on 29 males and 2 females.

The Demographic data is depicted in Table 1.The marijuana use data was available for 24 of the participants in the users group. All 24 (100%) of the users consumed marijuana via smoking. Additionally, 3 (12.5%) consumed as bhang, and 3 (12.5%) in edible form. The reasons for use were mainly due to peer pressure (14; 58.3%) or for relaxation/creativity enhancement purposes (14; 58.3%). Only 3 (12.5%) of the individuals used marijuana as a form of stress relief. 11 (45.8%) of individuals used during morning hours, 12 (50%) during the evening hours, and 21 (87.5%) during the night hours. Figure 1 describes the pattern of use of marijuana divided by the pre-specified time of day. Two dominant patterns of use can be observed. 9 (37.5%) individuals used during all three categories of the day, and the second pattern where individuals used only during the night hours (10; 41.7%).  

The Table 2 shows the distribution of scores between the two groups among the different characteristics of the MoCA assessment tool.

Out of the 31 subjects in the users group, 16 (51.6%) were found to have cognitive impairment (total score < 26) compared to 3 (9.7%) subjects in the control group

A Mann Whitney U test showed a significant difference between the total score of the MoCA test in the chronic marijuana user group (Median = 25) when compared to the control group (Median = 28); U = 181, p < 0.001. Among the different categories of the MoCA tool, there was a significant difference between the users group and the control group in the categories of Visuospatial function, Attention and Language as depicted by the Mann Whitney U test shown in Table 2. Correction for multiple analyses was not applied to the above analysis.

Discussion

It was found that significantly more individuals who were chronic cannabis users were found to have cognitive impairment than those who have never used cannabis. Among the aspects of the MoCA assessment tool, Visuo-spatial skill was the most affected trait followed by Attention and Language.

Delayed Recall, was not different between the users and control group. However, some studies show that relative to nonusers, cannabis users were found to be impaired in several aspects of real-world memory functioning.10 A better test for memory is thus probably required for a more accurate measure of the effects of cannabis.

The numbers of female users in our study were significantly fewer than the number of male users. Reasons for this disparity in sex ratio could be social stigma associated with female drug abuse compared to that of male. The World Drug Report 2019 presents similar numbers.4

Similar to other addictive drugs, fewer females than males use marijuana. For females who do use marijuana, however, the effects can be different than for male users. Research indicates that marijuana impairs spatial memory in women more than it does in men, while males show a greater marijuana-induced high.11

The percentage of drug users living in hostels (48%) was higher than the percentage of nonusers (32%). This brings into question the role of a healthy environment, parental supervision and peer pressure, all of which are known to affect the habits of an individual. Based on the questionnaire filled by the subjects, peer pressure and parties were ranked the highest reasons of consumption. This observation agrees with a French study done on cannabis dependent individuals which demonstrated that cannabis dependence in adolescents and young adults is related to great psychological distress. The study emphasizes on the importance of substance use prevention as early as middle school.

In terms of monetary funds (either monthly income or pocket money given by parents), both groups did not show a significant difference. The consumption of cannabis based on the socio-economic class of the individual was not determined due to the small sample size.

The limitations of the study are the small sample size in view of the feasibility and consent. Snowball sampling may have led to a selection bias in the users group with regard to common drug dealers and the quality of the marijuana used. The MoCA test is a screening tool and cannot be used to diagnose cognitive impairment. More studies are needed using a battery of neuropsychiatric tests administered by trained psychologists to address the issue of cognitive impairment in marijuana use.

Conclusion

There are negative effects of chronic cannabis use on the cognitive levels of the individual; cognition of chronic users being significantly lower than that of non-users. Visuo-spatial skills and attention were two aspects of cognition that were significantly affected, with majority of users being male. Economic independence increased the prevalence of cannabis use, as did absence of parental/ family supervision. Peer pressure was also a major contributor in development of cannabis dependence.

In view of the results of this study, it is suggested that complete and thorough research be done on cannabis use in the country. More awareness needs to be created about the effects of this drug, as has been done for alcohol and tobacco consumption. The risk factors must be identified for drug abuse and dependence, thereby aiding in its prevention.

Supporting File
References

1. Iversen L. Cannabis and the brain. Brain. 2003 Jun 1;126(6):1252-70.

2. Grotenhermen F. Pharmacokinetics and pharmacodynamics of cannabinoids. Clinical pharmacokinetics. 2003 Apr 1;42(4):327-60.

3. Guillem E, Arbabzadeh-Bouchez S, Vorspan F, Bellivier F. Comorbidity in 207 cannabis users in a specific outpatient setting. L'Encephale. 2015 Jun;41:S7-12.

4. UNODC. World Drug Report 2019. 2019. Available from: https://www.un-ilibrary.org/ content/publication/a4dd519a-en

5. Board INC. Report of the International Narcotics Control Board for 2018. 2019. Available from: https://www.un-ilibrary.org/ content/publication/84159c71-en

6. Montreal Cognitive Assessment. Available from http://www.mocatest.org

7. Trzepacz PT, Hochstetler H, Wang S, Walker B, Saykin AJ, Alzheimer’s Disease Neuroimaging Initiative. Relationship between the Montreal Cognitive Assessment and Mini-mental State Examination for assessment of mild cognitive impairment in older adults. BMC geriatrics. 2015 Dec 1;15(1):107.

8. Nasreddine ZS, Phillips NA, Bédirian V, Charbonneau S, Whitehead V, Collin I, Cummings JL, Chertkow H. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. Journal of the American Geriatrics Society. 2005 Apr;53(4):695-9.

9. Fisk JE, Montgomery C. Real-world memory and executive processes in cannabis users and non-users. Journal of Psychopharmacology. 2008 Sep;22(7):727-36.

10. NIDA. "Substance Use in Women." National Institute on Drug Abuse, 22 Jan. 2020, https:// www.drugabuse.gov/publications/researchreports/substance-use-in-women.

11. Dorard G, Bungener C, Phan O, Edel Y, Corcos M, Berthoz S. Which psychiatric comorbidities in cannabis dependence during adolescence? Comparison of outpatients and controls. L'Encephale. 2018 Feb;44(1):2-8.

HealthMinds Logo
RGUHS Logo

© 2024 HealthMinds Consulting Pvt. Ltd. This copyright specifically applies to the website design, unless otherwise stated.

We use and utilize cookies and other similar technologies necessary to understand, optimize, and improve visitor's experience in our site. By continuing to use our site you agree to our Cookies, Privacy and Terms of Use Policies.